Synonym |
Thai / English name |
Part Used : ใบActivity : ARYL HYDROCARBON RECEPTOR ACTIVATIONSolvent/Active Compound : The standardized Ginkgo biloba leaf extract (EGb 761)Type of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : EGb 761 100 mcg/mlDuration : Transfected cells were then treated with EGb 761 for 24 h.Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : PositiveRemark : Result: EGb 761 and its flavonoids increased the expression of UGT1A1-gtPBREM reporter gene, whereas all the terpenoids tested exhibit no effects on aryl hydrocarbon recepotr (AhR) activity.Note : Abbreviations: AhR = Arylhydrocarbon receptor GA = Ginkgolide A, GB = Ginkgolide B, CAR = Constitutive androstane receptor, BB = Bilobalide, Que = Quercetin, Kae = Kaempferol, Tam = Tamarexetin
Part Used : ใบActivity : ARYL HYDROCARBON RECEPTOR ACTIVATIONSolvent/Active Compound : quercetin (Que)Type of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : Que 25 mcg/mlDuration : Transfected cells were then treated with Que for 24 h.Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : PositiveRemark : Result: EGb 761 and its flavonoids increased the expression of UGT1A1-gtPBREM reporter gene, whereas all the terpenoids tested exhibit no effects on aryl hydrocarbon recepotr (AhR) activity.Note : Abbreviations: AhR = Arylhydrocarbon receptor GA = Ginkgolide A, GB = Ginkgolide B, CAR = Constitutive androstane receptor, BB = Bilobalide, Que = Quercetin, Kae = Kaempferol, Tam = Tamarexetin
Part Used : ใบActivity : ARYL HYDROCARBON RECEPTOR ACTIVATIONSolvent/Active Compound : kaempferol (Kae)Type of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : Kae 20 mcg/mlDuration : Transfected cells were then treated with Kae for 24 h.Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : PositiveRemark : Result: EGb 761 and its flavonoids increased the expression of UGT1A1-gtPBREM reporter gene, whereas all the terpenoids tested exhibit no effects on aryl hydrocarbon recepotr (AhR) activity.Note : Abbreviations: AhR = Arylhydrocarbon receptor GA = Ginkgolide A, GB = Ginkgolide B, CAR = Constitutive androstane receptor, BB = Bilobalide, Que = Quercetin, Kae = Kaempferol, Tam = Tamarexetin
Part Used : ใบActivity : ARYL HYDROCARBON RECEPTOR ACTIVATIONSolvent/Active Compound : tamarixetin (Tam)Type of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : Tam 10 mcg/mlDuration : Transfected cells were then treated with Tam for 24 h.Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : PositiveRemark : Result: EGb 761 and its flavonoids increased the expression of UGT1A1-gtPBREM reporter gene, whereas all the terpenoids tested exhibit no effects on aryl hydrocarbon recepotr (AhR) activity.Note : Abbreviations: AhR = Arylhydrocarbon receptor GA = Ginkgolide A, GB = Ginkgolide B, CAR = Constitutive androstane receptor, BB = Bilobalide, Que = Quercetin, Kae = Kaempferol, Tam = Tamarexetin
Part Used : ใบActivity : ARYL HYDROCARBON RECEPTOR ACTIVATIONSolvent/Active Compound : ginkgolide A (GA)Type of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : GA 50 microMDuration : Transfected cells were then treated with GA for 24 h.Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : NegativeRemark : Result: EGb 761 and its flavonoids increased the expression of UGT1A1-gtPBREM reporter gene, whereas all the terpenoids tested exhibit no effects on aryl hydrocarbon recepotr (AhR) activity.Note : Abbreviations: AhR = Arylhydrocarbon receptor GA = Ginkgolide A, GB = Ginkgolide B, CAR = Constitutive androstane receptor, BB = Bilobalide, Que = Quercetin, Kae = Kaempferol, Tam = Tamarexetin
Part Used : ใบActivity : ARYL HYDROCARBON RECEPTOR ACTIVATIONSolvent/Active Compound : ginkgolide B (GB)Type of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : GB 50 microMDuration : Transfected cells were then treated with GB for 24 h.Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : NegativeRemark : Result: EGb 761 and its flavonoids increased the expression of UGT1A1-gtPBREM reporter gene, whereas all the terpenoids tested exhibit no effects on aryl hydrocarbon recepotr (AhR) activity.Note : Abbreviations: AhR = Arylhydrocarbon receptor GA = Ginkgolide A, GB = Ginkgolide B, CAR = Constitutive androstane receptor, BB = Bilobalide, Que = Quercetin, Kae = Kaempferol, Tam = Tamarexetin
Part Used : ใบActivity : ARYL HYDROCARBON RECEPTOR ACTIVATIONSolvent/Active Compound : bilobalide (BB)Type of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : BB 50 microMDuration : Transfected cells were then treated with BB for 24 h.Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : NegativeRemark : Result: EGb 761 and its flavonoids increased the expression of UGT1A1-gtPBREM reporter gene, whereas all the terpenoids tested exhibit no effects on aryl hydrocarbon recepotr (AhR) activity.Note : Abbreviations: AhR = Arylhydrocarbon receptor GA = Ginkgolide A, GB = Ginkgolide B, CAR = Constitutive androstane receptor, BB = Bilobalide, Que = Quercetin, Kae = Kaempferol, Tam = Tamarexetin
Part Used : ไม่ระบุActivity : ARYL HYDROCARBON RECEPTOR ACTIVATIONSolvent/Active Compound : Ginkgo biloba extract*Type of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : Ginkgo biloba extract 25, 50, 100, 200, or 300 mcg/mLDuration : MCF-10A cells were treated with G. biloba extract once every 24 h for 48 h.Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : NegativeRemark : Result: As analyzed by real-time PCR analysis with gene-specific primers, G. biloba extract did not upregulate AhR gene expression.Note : Solvent/compound: Ginkgo biloba extract contained 6.2% w/w terpene trilactones, consisting of bilobalide (2.8%), ginkgolide A (1.1%), ginkgolide B (0.3%), ginkgolide C (1.4%), and ginkgolide J (0.6%). It also contained 21% w/w flavonols (as sum of the aglycone and glycosides), consisting of quercetin (10.6%), kaempferol (6.3%), and isorhamnetin (4.1%).
Part Used : ไม่ระบุActivity : ARYL HYDROCARBON RECEPTOR ACTIVATIONSolvent/Active Compound : Ginkgo biloba extract*Type of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : Ginkgo biloba extract 25, 50, 100, 200 or 300 mcg/mLDuration : MCF-10A cells were treated with G. biloba extract and 3',4'-dimethoxyflavone (DMF; an antagonist of AhR) at 1, 5, and 10 mmol/L once every 24 h for 48 h.Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : PositiveRemark : Result: As shown by the dose-response, there was a progressive increase in AhR-dependent reporter activity by the Ginkgo biloba extract over the range of concentrations (25-300 mg/mL) investigated in the CYP1B1 and CYP1A1 gene expression experiments.Note : Solvent/compound: Ginkgo biloba extract contained 6.2% w/w terpene trilactones, consisting of bilobalide (2.8%), ginkgolide A (1.1%), ginkgolide B (0.3%), ginkgolide C (1.4%), and ginkgolide J (0.6%). It also contained 21% w/w flavonols (as sum of the aglycone and glycosides), consisting of quercetin (10.6%), kaempferol (6.3%), and isorhamnetin (4.1%).
Part Used : ไม่ระบุActivity : ARYL HYDROCARBON RECEPTOR ACTIVATIONSolvent/Active Compound : bilobalideType of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : bilobalide 2.8 mcg/mLDuration : MCF-10A cells were treated with bilobalide for 24 hType of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : NegativeRemark : Result: None of the terpene trilactones increased CYP1B1 or CYP1A1 mRNA expression. These compounds also and had no effect on AhR dependent report activity.Note : Solvent/compound: Ginkgo biloba extract contained 6.2% w/w terpene trilactones, consisting of bilobalide (2.8%), ginkgolide A (1.1%), ginkgolide B (0.3%), ginkgolide C (1.4%), and ginkgolide J (0.6%). It also contained 21% w/w flavonols (as sum of the aglycone and glycosides), consisting of quercetin (10.6%), kaempferol (6.3%), and isorhamnetin (4.1%).